Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Lobular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01849250
What this trial is testing

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

Who this might be right for
Benign Breast NeoplasmDuctal Breast Carcinoma In SituInvasive Breast Carcinoma+9 more
National Cancer Institute (NCI) 65
Not applicableUnknownNCT02909426
What this trial is testing

The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness

Who this might be right for
Invasive CancerDuctal Carcinoma in Situ
Soonchunhyang University Hospital 11,880
Not applicableStudy completedNCT00182728
What this trial is testing

Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 89
Not applicableUnknownNCT04021069
What this trial is testing

Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer

Who this might be right for
Breast CancerInvasive Ductal Breast CarcinomaInvasive Lobular Breast Carcinoma
Sunnybrook Health Sciences Centre 800
Testing effectiveness (Phase 2)Study completedNCT01082211
What this trial is testing

Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group 65
Testing effectiveness (Phase 2)Looking for participantsNCT06677944
What this trial is testing

Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in SituInvasive Breast Cancer
Yonsei University 47
Testing effectiveness (Phase 2)Looking for participantsNCT07702292
What this trial is testing

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Who this might be right for
Colorectal CancerEpithelial Ovarian CancerGastric Cancer (GC)+2 more
Blue Earth Diagnostics 71
Testing effectiveness (Phase 2)Study completedNCT02682693
What this trial is testing

Denosumab as an add-on Neoadjuvant Treatment (GeparX)

Who this might be right for
Breast Cancer Female NOSTubular Breast Cancer Stage IIMucinous Breast Cancer Stage II+4 more
GBG Forschungs GmbH 780
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Not applicableStudy completedNCT04498611
What this trial is testing

Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy

Who this might be right for
Carcinoma, Ductal, BreastInvasive Breast CancerIMAGE
Seoul National University Hospital 113
Large-scale testing (Phase 3)Study completedNCT00433589
What this trial is testing

Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 6,600
Not applicableStudy completedNCT04245150
What this trial is testing

Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity

Who this might be right for
DCISInvasive Breast Cancer
Case Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Study completedNCT00096343
What this trial is testing

Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Alabama at Birmingham 31
Not applicableStudy completedNCT00602628
What this trial is testing

Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 60
Not applicableActive Not RecruitingNCT05318274
What this trial is testing

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

Who this might be right for
Ductal Breast Carcinoma in SituInvasive Breast CancerEarly-stage Breast Cancer+4 more
Coordinación de Investigación en Salud, Mexico 72
Early research (Phase 1)Study completedNCT04750473
What this trial is testing

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Lobular CarcinomaMetastatic Breast Lobular Carcinoma+1 more
Emory University 20
Not applicableEnded earlyNCT03560102
What this trial is testing

Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer

Who this might be right for
Breast Cancer, Invasive Ductal
Kantonsspital Winterthur KSW 1
Large-scale testing (Phase 3)Active Not RecruitingNCT01272037
What this trial is testing

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast Carcinoma+2 more
National Cancer Institute (NCI) 5,018
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Next Page